JP2001512748A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001512748A5 JP2001512748A5 JP2000506324A JP2000506324A JP2001512748A5 JP 2001512748 A5 JP2001512748 A5 JP 2001512748A5 JP 2000506324 A JP2000506324 A JP 2000506324A JP 2000506324 A JP2000506324 A JP 2000506324A JP 2001512748 A5 JP2001512748 A5 JP 2001512748A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- antigen
- cell
- vaccine
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 description 26
- 102000036639 antigens Human genes 0.000 description 26
- 108091007433 antigens Proteins 0.000 description 26
- 206010022000 influenza Diseases 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 11
- 229960005486 vaccine Drugs 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 108010052285 Membrane Proteins Proteins 0.000 description 4
- 102000018697 Membrane Proteins Human genes 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 2
- 229940021995 DNA vaccine Drugs 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 description 2
- 206010046865 Vaccinia virus infection Diseases 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 208000007089 vaccinia Diseases 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002480 immunoprotective effect Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 208000037799 influenza C Diseases 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 108010044241 tetanus toxin fragment C Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97202434.3 | 1997-08-05 | ||
| EP97202434 | 1997-08-05 | ||
| PCT/EP1998/005106 WO1999007839A2 (en) | 1997-08-05 | 1998-08-05 | Immunoprotective influenza antigen and its use in vaccination |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009239092A Division JP2010059164A (ja) | 1997-08-05 | 2009-10-16 | 新しい免疫防御性インフルエンザ抗原及びそのワクチン接種への使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001512748A JP2001512748A (ja) | 2001-08-28 |
| JP2001512748A5 true JP2001512748A5 (enExample) | 2006-01-12 |
| JP5132851B2 JP5132851B2 (ja) | 2013-01-30 |
Family
ID=8228624
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000506324A Expired - Lifetime JP5132851B2 (ja) | 1997-08-05 | 1998-08-05 | 新しい免疫防御性インフルエンザ抗原及びそのワクチン接種への使用 |
| JP2009239092A Pending JP2010059164A (ja) | 1997-08-05 | 2009-10-16 | 新しい免疫防御性インフルエンザ抗原及びそのワクチン接種への使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009239092A Pending JP2010059164A (ja) | 1997-08-05 | 2009-10-16 | 新しい免疫防御性インフルエンザ抗原及びそのワクチン接種への使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7732130B2 (enExample) |
| EP (1) | EP0996717B1 (enExample) |
| JP (2) | JP5132851B2 (enExample) |
| AT (1) | ATE312172T1 (enExample) |
| AU (1) | AU745951B2 (enExample) |
| CA (1) | CA2297786C (enExample) |
| DE (1) | DE69832706T2 (enExample) |
| DK (1) | DK0996717T3 (enExample) |
| ES (1) | ES2255181T3 (enExample) |
| WO (1) | WO1999007839A2 (enExample) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7731972B1 (en) | 2000-02-04 | 2010-06-08 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Immunoprotective influenza antigen and its use in vaccination |
| WO1999007839A2 (en) | 1997-08-05 | 1999-02-18 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Immunoprotective influenza antigen and its use in vaccination |
| DK1135162T3 (da) | 1998-11-30 | 2009-01-19 | Cytos Biotechnology Ag | Ordnet molekylær præsentation af allergener, fremstillingsfremgangsmåde samt anvendelse |
| GB0008582D0 (en) * | 2000-04-08 | 2000-05-31 | Adprotech Plc | DNA immunization vectors |
| DE60143476D1 (de) * | 2000-04-14 | 2010-12-30 | Wisconsin Alumni Res Found | Mutiertes ionenkanalprotein enthaltende viren |
| AU2001252390A1 (en) * | 2000-05-01 | 2001-11-12 | Powderject Vaccines, Inc. | Nucleic acid immunization |
| CA2407897A1 (en) | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Molecular antigen arrays and vaccines |
| GB0025229D0 (en) * | 2000-10-14 | 2000-11-29 | Adprotech Ltd | Veterinary immunisation vectors |
| US7320793B2 (en) | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
| US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
| US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
| US7361352B2 (en) * | 2001-08-15 | 2008-04-22 | Acambis, Inc. | Influenza immunogen and vaccine |
| EP2196217A1 (en) | 2001-09-14 | 2010-06-16 | Cytos Biotechnology AG | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| US7351413B2 (en) | 2002-02-21 | 2008-04-01 | Lorantis, Limited | Stabilized HBc chimer particles as immunogens for chronic hepatitis |
| GB0204154D0 (en) * | 2002-02-22 | 2002-04-10 | Adprotech Ltd | Cat immunisation vectors |
| WO2003078600A2 (en) * | 2002-03-13 | 2003-09-25 | Kirin Beer Kabushiki Kaisha | Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| WO2004007538A2 (en) | 2002-07-17 | 2004-01-22 | Cytos Biotechnology Ag | Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| MXPA04012010A (es) | 2002-07-18 | 2005-03-07 | Cytos Biotechnology Ag | Conjugados de hapteno-portador que comprende particulas similares a virus, y usos de los mismos. |
| DK1524994T3 (da) | 2002-07-19 | 2011-08-15 | Cytos Biotechnology Ag | Vaccinesammensætninger indeholdende amyloid beta 1-6-antigen-arrays |
| EP1618191A2 (en) * | 2003-04-23 | 2006-01-25 | Wisconsin Alumni Research Foundation | Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| KR101206544B1 (ko) * | 2003-06-23 | 2012-11-30 | 박스터 헬쓰케어 에스.에이. | 백신용 담체 단백질 |
| AU2005337178A1 (en) | 2004-11-19 | 2007-04-19 | Wisconsin Alumni Research Foundation | Recombinant influenza vectors with tandem transcription units |
| EP2295465B1 (en) | 2004-12-06 | 2013-02-13 | Kyowa Hakko Kirin Co., Ltd. | Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| US20090162400A1 (en) * | 2004-12-21 | 2009-06-25 | Powell Thomas J | Compositions of influenza viral proteins and methods of use thereof |
| EP1951862B1 (en) * | 2005-11-07 | 2013-07-24 | MicroVAX, LLC | Cd40 ligand fusion protein vaccine |
| ATE552846T1 (de) | 2005-12-06 | 2012-04-15 | Yeda Res & Dev | Verbesserter grippeimpfstoff |
| ES2555544T3 (es) * | 2006-03-07 | 2016-01-04 | Vaxinnate Corporation | Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas |
| AU2007245192B2 (en) | 2006-03-31 | 2012-04-12 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
| BRPI0714721A2 (pt) | 2006-07-14 | 2013-04-24 | Sanofi Pasteur Biologics Co | construÇço de vacinas de vÍrus recombinante por inserÇço direta mediada por transpàson de determinantes imunolàgicos estranhos em proteÍnas de vÍrus vetorial |
| CA2664791A1 (en) | 2006-09-29 | 2008-08-21 | Sanofi Pasteur Biologics Co. | Recombinant rhinovirus vectors |
| JP2010508860A (ja) * | 2006-11-15 | 2010-03-25 | フォリア バイオテック インコーポレイテッド | パパイヤモザイクウイルスに基づくインフルエンザ用ワクチン |
| US9474798B2 (en) | 2007-06-18 | 2016-10-25 | Wisconsin Alumni Research Foundation | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
| ES2539818T3 (es) | 2007-08-02 | 2015-07-06 | Biondvax Pharmaceuticals Ltd. | Vacunas contra la gripe multiepitópicas multiméricas |
| US9592285B2 (en) | 2007-11-12 | 2017-03-14 | The Trustees Of The University Of Pennsylvania | Vaccines against multiple subtypes of influenza virus |
| AU2009236585B2 (en) | 2008-04-18 | 2013-03-07 | Vaxinnate Corporation | Deletion mutants of flagellin and methods of use |
| WO2010012069A1 (en) * | 2008-07-30 | 2010-02-04 | Folio Biotech Inc. | Multivalent vaccines based on papaya mosaic virus and uses thereof |
| EP2168987A1 (en) * | 2008-09-22 | 2010-03-31 | Mucosis B.V. | Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| RU2012107702A (ru) * | 2009-07-31 | 2013-09-10 | Пэксвэкс, Инк. | Векторы на основе аденовирусов |
| ES2682998T3 (es) | 2009-08-28 | 2018-09-24 | The Chemo-Sero-Therapeutic Research Institute | Vacuna de péptido modificado derivada de M2 de influenza |
| WO2011046925A1 (en) * | 2009-10-12 | 2011-04-21 | Technovax, Inc. | Respiratory syncytial virus (rsv) virus-like particles (vlps) |
| JP2013507990A (ja) | 2009-10-26 | 2013-03-07 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス |
| WO2011054995A2 (es) | 2009-11-06 | 2011-05-12 | Chimera Pharma, S. L. U. | VACUNAS PROFILACTICAS DE GRIPE A PARTIR DE CAPSIDAS VIRALES DE BIRNAVIRUS CONTENIENDO EL ANTIGENO M2e DEL VIRUS DE LA GRIPE |
| US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
| CA2828068C (en) | 2011-02-22 | 2019-03-19 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| JP2014527799A (ja) | 2011-08-26 | 2014-10-23 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | 変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス |
| US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
| EP3022296B1 (en) | 2013-07-15 | 2022-12-28 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs |
| WO2015196150A2 (en) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
| US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
| EP3103474A1 (en) * | 2015-06-12 | 2016-12-14 | Institut Pasteur | Live recombinant measles-m2 virus and its use in eliciting immunity against influenza viruses |
| US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
| JP2019510481A (ja) | 2016-02-19 | 2019-04-18 | ウィスコンシン アルムニ リサーチ ファンデイション | ワクチン開発のための改善されたｂ型インフルエンザウイルス複製 |
| EP3700562A1 (en) | 2017-10-25 | 2020-09-02 | Wisconsin Alumni Research Foundation (WARF) | Recombinant influenza viruses with stabilized ha for replication in eggs |
| JP7783047B2 (ja) | 2018-08-07 | 2025-12-09 | ウィスコンシン アルムニ リサーチ ファンデイション | 組換えの生物学的に封じ込められたフィロウイルスワクチン |
| EP3840780A1 (en) | 2018-08-20 | 2021-06-30 | Wisconsin Alumni Research Foundation | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein |
| EP3914295A2 (en) | 2019-01-23 | 2021-12-01 | Yoshihiro Kawaoka | Mutations that confer genetic stability to additional genes in influenza viruses |
| US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
| WO2020223699A1 (en) | 2019-05-01 | 2020-11-05 | Wisconsin Alumni Research Foundation (Warf) | Improved influenza virus replication for vaccine development |
| WO2021041624A2 (en) | 2019-08-27 | 2021-03-04 | Yoshihiro Kawaoka | Recombinant influenza viruses with stabilized ha for replication in eggs |
| JP2023511444A (ja) | 2020-01-24 | 2023-03-17 | ウィスコンシン アルムニ リサーチ ファンデイション | 安定化されたｎａを有する組換えインフルエンザウイルス |
| US12290562B2 (en) | 2020-03-25 | 2025-05-06 | Wisconsin Alumni Research Foundation (Warf) | Recombinant multivalent influenza viruses |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3919044A (en) * | 1973-03-28 | 1975-11-11 | Armour Pharma | Processes for concentrating and purifying viruses and viral antigens |
| NZ219516A (en) * | 1987-02-10 | 1991-02-26 | Wellcome Found | Fusion proteins of hbcag (hepatitis b virus core antigen) |
| WO1992022575A1 (en) * | 1991-06-19 | 1992-12-23 | Sri International | M-protein peptides of influenza virus as antiviral agents |
| FR2695563B1 (fr) | 1992-09-11 | 1994-12-02 | Pasteur Institut | Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires. |
| ATE221387T1 (de) * | 1993-04-27 | 2002-08-15 | United Biomedical Inc | Immunogene lhrh peptidkonstrukion und synthetische, universale immunstimulatoren als impfstoffe |
| US5759551A (en) | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
| AU7235794A (en) * | 1993-07-30 | 1995-02-28 | Medeva Holdings B.V. | Vaccine compositions |
| US5691189A (en) * | 1994-01-19 | 1997-11-25 | Bristol-Myers Squibb Company | Saccharomyces cerevisiae expressing M2 protein of influenza A virus |
| GB9424631D0 (en) * | 1994-12-06 | 1995-01-25 | Lynxvale Ltd | Modulating the immune response |
| GB9521568D0 (en) * | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
| EP0941315B1 (en) | 1996-11-26 | 2006-03-01 | Stressgen Biotechnologies Corporation | Fusion proteins containing stress proteins for inducing immune responses |
| WO1999007839A2 (en) | 1997-08-05 | 1999-02-18 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Immunoprotective influenza antigen and its use in vaccination |
| US6169175B1 (en) * | 1997-08-06 | 2001-01-02 | Centers For Disease Control And Prevention | Preparation and use of recombinant influenza A virus M2 construct vaccines |
| US20020015951A1 (en) | 2000-01-06 | 2002-02-07 | Bader Joel S. | Method of analyzing a nucleic acid |
-
1998
- 1998-08-05 WO PCT/EP1998/005106 patent/WO1999007839A2/en not_active Ceased
- 1998-08-05 CA CA2297786A patent/CA2297786C/en not_active Expired - Lifetime
- 1998-08-05 AU AU93416/98A patent/AU745951B2/en not_active Expired
- 1998-08-05 ES ES98946321T patent/ES2255181T3/es not_active Expired - Lifetime
- 1998-08-05 JP JP2000506324A patent/JP5132851B2/ja not_active Expired - Lifetime
- 1998-08-05 DK DK98946321T patent/DK0996717T3/da active
- 1998-08-05 AT AT98946321T patent/ATE312172T1/de active
- 1998-08-05 EP EP98946321A patent/EP0996717B1/en not_active Revoked
- 1998-08-05 DE DE69832706T patent/DE69832706T2/de not_active Expired - Lifetime
-
2006
- 2006-03-14 US US11/374,922 patent/US7732130B2/en active Active
-
2009
- 2009-10-16 JP JP2009239092A patent/JP2010059164A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001512748A5 (enExample) | ||
| CA2297786A1 (en) | New immunoprotective influenza antigen and its use in vaccination | |
| US11938221B2 (en) | Multivalent nanoparticle-based vaccines | |
| JP7465310B2 (ja) | 多用途性且つ効率的な遺伝子発現のためのｒｎａレプリコン | |
| JP7788787B2 (ja) | 遺伝子発現増強のための組成物および方法 | |
| Moser et al. | Virosomal adjuvanted antigen delivery systems | |
| Arnold et al. | Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit | |
| EP2204187A1 (en) | Human flu vaccine containing four influenza peptides | |
| US20090304735A1 (en) | Immunogenic Compositions | |
| EA012037B1 (ru) | Поливалентные вакцины, содержащие рекомбинантные вирусные векторы | |
| AU682344B2 (en) | Recombinant poxvirus and streptococcal M protein vaccine | |
| Plotkin | Six revolutions in vaccinology | |
| US11352416B2 (en) | Mosaic chimeric viral vaccine particle | |
| US5882650A (en) | Cross-reactive influenza A immunization | |
| WO2002074920A3 (en) | A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same | |
| Yang et al. | Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection | |
| Skrastina et al. | Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein | |
| Chengalvala et al. | Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid | |
| CN118750594B (zh) | 一种二价猪口蹄疫mRNA疫苗及其制备方法和应用 | |
| Mazeike et al. | Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope | |
| Beauverger et al. | Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes | |
| JPWO2021051153A5 (enExample) | ||
| Zuckerman | Subunit, recombinant and synthetic hepatitis B vaccines | |
| Le Grand et al. | Recombinant vaccines: development, production, and application | |
| Cogan | Towards new vaccines against virus infection:(European Molecular Biology Organization Workshop) 20–23 June 1983, Espoo, Finland |